CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CARLSMED, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.66+0.25 (+1.86%)
Close on Oct 19, 2026
- Market cap
- $371.43M
- P/E (TTM)
- –
- Dividend yield
- –
Carlsmed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Carlsmed | Industry median |
|---|---|---|
| Market Cap | $372.96M | $230.55M |
| Enterprise Value | $302.71M | $202.97M |
| PS Ratio | 5.89 | 3.11 |
| PB Ratio | 4.43 | 3.14 |
| P/TBV Ratio | 4.43 | 4.57 |
Enterprise value
| Measure | Carlsmed | Industry median |
|---|---|---|
| EV / Sales | 4.78 | 2.92 |
Income (trailing twelve months)
| Measure | Carlsmed | Industry median |
|---|---|---|
| Revenue | $63.30M | $102.39M |
| Gross Profit | $48.50M | $60.36M |
| Operating Income | -$38.67M | -$4.31M |
| Net Income | -$36.35M | -$6.57M |
| EBITDA | -$38.26M | -$1.98M |
Margins
| Measure | Carlsmed | Industry median |
|---|---|---|
| Gross Margin | 76.6% | 55.1% |
| Operating Margin | -61.1% | -6.04% |
| Profit Margin | -57.4% | -10.5% |
| EBITDA Margin | -60.4% | -2.67% |
| FCF Margin | -54.6% | -0.30% |
Returns
| Measure | Carlsmed | Industry median |
|---|---|---|
| Return on Equity (ROE) | -6196.9% | -19.2% |
| Return on Assets (ROA) | -42.4% | -13.3% |
| Return on Capital Employed (ROCE) | -36.5% | -9.07% |
Growth
| Measure | Carlsmed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 65.4% | 8.85% |
Balance sheet
| Measure | Carlsmed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $70.24M | $37.33M |
| Net Cash (Debt) | $70.24M | $3.92M |
| Net Cash Per Share | $2.57 | $0.28 |
| Equity (Book Value) | $84.25M | $57.36M |
| Book Value Per Share | $3.09 | $2.81 |
| Tangible Book Value | $84.25M | $10.71M |
| Working Capital | $97.20M | $54.64M |
Financial position
| Measure | Carlsmed | Industry median |
|---|---|---|
| Current Ratio | 8.84 | 2.50 |
| Quick Ratio | 6.78 | 1.54 |
| Interest Coverage | -28.98 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Carlsmed | Industry median |
|---|---|---|
| Operating Cash Flow | -$34.15M | -$653.46K |
| Capital Expenditures | -$432.00K | -$3.69M |
| Free Cash Flow | -$34.58M | -$835.02K |
| FCF Per Share | -$1.27 | -$0.02 |
Efficiency
| Measure | Carlsmed | Industry median |
|---|---|---|
| Asset Turnover | 0.74 | 0.59 |
| Inventory Turnover | 8.85 | 2.21 |
| Revenue Per Employee | $2.64M | $322.57K |
| Profits Per Employee | -$1.51M | -$51.88K |
| Employee Count | 24 | 185 |
Dividends and yields
| Measure | Carlsmed | Industry median |
|---|---|---|
| Earnings Yield | -9.75% | -6.91% |
| FCF Yield | -9.27% | -0.56% |
Shares
| Measure | Carlsmed | Industry median |
|---|---|---|
| Shares Outstanding | 27,302,700 | 44,856,700 |
| Shares Change (YoY) | 495.4% | 3.35% |
| Shares Change (QoQ) | 0.16% | 0.27% |
| Float | 5,170,010 | 37,097,900 |
| Shares Held by Insiders | 81.1% | 10.6% |
| Shares Held by Institutions | 20.9% | 63.5% |
Taxes
| Measure | Carlsmed | Industry median |
|---|---|---|
| Income Tax | $0 | $1.52M |
Scores
| Measure | Carlsmed | Industry median |
|---|---|---|
| Altman Z-Score | 5.61 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -1.83 | -2.64 |
Calculated by StockData from Carlsmed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.